Supply Chain | December 23, 2023
UPM Biomedicals enters into distribution agreement with Brinter for GrowInk bioinks
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership
The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC
Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)